Antimicrobial

Aridis Pharmaceuticals Announces $2 Million Offering

Los Gatos, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (OTC: ARDS), a biopharmaceutical company focused on the…

1 year ago

T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirements

LEXINGTON, Mass., July 31, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing…

1 year ago

Spero Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 PIVOT-PO Trial of Tebipenem HBr

Phase 3 PIVOT-PO trial is expected to begin with First Patient, First Visit in 4Q 2023 Spero to receive $30…

1 year ago

Recce Pharmaceuticals to Present at the 2023 Military Health System Research Symposium (MHSRS)

SYDNEY, Australia, July 31, 2023 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing…

1 year ago

Fortifeye Vitamins Unveils the Cutting-Edge, Next Gen, Zinc-Free Macular Defense Formula, Elevating Eye Health to New Heights

Fortifeye Vitamins Releases Next Gen, Zinc-Free Macular DefenseOCALA, FL / ACCESSWIRE / July 28, 2023 / Fortifeye Vitamins, a pioneering…

1 year ago

T2 Biosystems to Attend Upcoming Investor Conferences

LEXINGTON, Mass., July 28, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens…

1 year ago

CorMedix Inc. to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 8, 2023

BERKELEY HEIGHTS, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…

1 year ago

Pressure BioSciences Launches Program to Evaluate Company’s Patented UltraShear Process in Breakthrough Application to Extend Shelf-Life of Fresh Produce

Scientific Publications Demonstrate Effectiveness of CBD and Essential Oil Nanoemulsions in Shelf-Life Extension of Fruits and Vegetables; PBI Initiating Studies…

1 year ago

Fortifeye Vitamins Breaks New Ground With Next Gen Zinc-Free Macular Degeneration Formula

Fortifeye Vitamins Introduces Next Gen Zinc-Free Macular DefenseOCALA, FL / ACCESSWIRE / July 25, 2023 / Fortifeye Vitamins, a leading…

1 year ago

AUROBAC THERAPEUTICS welcomes two new independent members to its Board: Manos Perros, as Chairman, and Marco Taglietti

These new appointments bring extensive US and international experience in company leadership and development of anti-infectives from R&D to commercialization.Lyon…

1 year ago